Turmeric and Nabumetone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Turmeric (turmeric) and Nabumetone (nabumetone). Common drug interactions include pruritus among females and haemolytic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Turmeric and Nabumetone. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Turmeric?

Turmeric has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 16,564 Turmeric users. Check the latest studies of Turmeric.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.



On Aug, 07, 2026

66 people who take Turmeric and Nabumetone together, and have interactions are studied.

Turmeric and Nabumetone drug interactions.

What are the common drug interactions of Turmeric and Nabumetone, by gender? *:

female:

  1. Pruritus (severe itching of the skin)
  2. Pain in extremity
  3. Weight decreased
  4. Blood pressure diastolic increased
  5. Blood pressure increased
  6. Blood pressure systolic increased
  7. Cough
  8. Dysstasia (difficulty in standing)
  9. Feeding disorder (when children refuse to eat certain food groups)
  10. Haematoma (collection of blood outside the blood vessels)

male:

  1. Haemolytic anaemia (anaemia due to haemolysis)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood creatinine increased
  5. Bursitis infective (the bursa can become infected, this is called infected bursitis)
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Hypoxia (low oxygen in tissues)
  9. Neuropathy peripheral (surface nerve damage)
  10. Pyrexia (fever)

What are the common drug interactions of Turmeric and Nabumetone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Increased appetite
  3. Migraine (headache)

40-49:

  1. Post procedural infection
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  3. Femoroacetabular impingement (a condition affecting the hip joint in young and middle-aged adults)
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  7. Dyspepsia (indigestion)
  8. Glycosylated haemoglobin increased
  9. Herpes virus infection
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

50-59:

  1. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  2. Metastatic neoplasm (spreadable cancer tumour)
  3. Pulmonary sarcoidosis (growth of tiny collections of inflammatory cells in lungs)
  4. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  5. Suicidal ideation
  6. Tooth disorder (tooth disease)
  7. Vision blurred
  8. Visual impairment
  9. Weight decreased
  10. Arthralgia (joint pain)

60+:

  1. Pruritus (severe itching of the skin)
  2. Cough
  3. Feeding disorder (when children refuse to eat certain food groups)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Inflammatory bowel disease
  6. Localised infection (infection at the single location)
  7. Lymph gland infection
  8. Oedema peripheral (superficial swelling)
  9. Oxygen saturation decreased
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 16.67%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 15.15%
  3. Immunodeficiency Common Variable: 10 people, 15.15%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 13.64%
  5. Pain: 5 people, 7.58%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 7.58%
  7. Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 7.58%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Turmeric and Nabumetone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Turmeric and Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Turmeric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Turmeric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nabumetone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on turmeric and nabumetone (the active ingredients of Turmeric and Nabumetone, respectively), and Turmeric and Nabumetone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: